調査レポート | • レポートコード：QYR2104Z4669 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、じん肺症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（有機粉じん、非有機物質）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・じん肺症の市場動向 ・企業の競争状況、市場シェア ・じん肺症の種類別市場規模（有機粉じん、非有機物質） ・じん肺症の用途別市場規模（病院、診療所、その他） ・じん肺症の北米市場規模2016-2027（アメリカ、カナダ） ・じん肺症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・じん肺症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・じん肺症の中南米市場規模2016-2027（メキシコ、ブラジル） ・じん肺症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Abbott、Eli Lilly、Sunpharma、Sanofi、Novo Nordisk、AstraZeneca） ・結論 |
Pneumoconiosis is an occupational lung disease and a restrictive lung disease caused by the inhalation of dust, often in mines and from agriculture.
In 2013 pneumoconiosis resulted in 260,000 deaths up from 251,000 deaths in 1990. Of these deaths 46,000 were due to silicosis, 24,000 due to asbestosis and 25,000 due to coal workers pneumoconiosis.
Market Analysis and Insights: Global Pneumoconiosis Market
The global Pneumoconiosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pneumoconiosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pneumoconiosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pneumoconiosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pneumoconiosis market.
Global Pneumoconiosis Scope and Market Size
Pneumoconiosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumoconiosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Cause and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Cause
Organic Dusts
Non-Organic Substances
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Abbott
Eli Lilly
Sunpharma
Sanofi
Novo Nordisk
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
1.2.2 Organic Dusts
1.2.3 Non-Organic Substances
1.3 Market by Application
1.3.1 Global Pneumoconiosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pneumoconiosis Market Perspective (2016-2027)
2.2 Pneumoconiosis Growth Trends by Regions
2.2.1 Pneumoconiosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pneumoconiosis Historic Market Share by Regions (2016-2021)
2.2.3 Pneumoconiosis Forecasted Market Size by Regions (2022-2027)
2.3 Pneumoconiosis Industry Dynamic
2.3.1 Pneumoconiosis Market Trends
2.3.2 Pneumoconiosis Market Drivers
2.3.3 Pneumoconiosis Market Challenges
2.3.4 Pneumoconiosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumoconiosis Players by Revenue
3.1.1 Global Top Pneumoconiosis Players by Revenue (2016-2021)
3.1.2 Global Pneumoconiosis Revenue Market Share by Players (2016-2021)
3.2 Global Pneumoconiosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumoconiosis Revenue
3.4 Global Pneumoconiosis Market Concentration Ratio
3.4.1 Global Pneumoconiosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumoconiosis Revenue in 2020
3.5 Pneumoconiosis Key Players Head office and Area Served
3.6 Key Players Pneumoconiosis Product Solution and Service
3.7 Date of Enter into Pneumoconiosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumoconiosis Breakdown Data by Cause
4.1 Global Pneumoconiosis Historic Market Size by Cause (2016-2021)
4.2 Global Pneumoconiosis Forecasted Market Size by Cause (2022-2027)
5 Pneumoconiosis Breakdown Data by Application
5.1 Global Pneumoconiosis Historic Market Size by Application (2016-2021)
5.2 Global Pneumoconiosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pneumoconiosis Market Size (2016-2027)
6.2 North America Pneumoconiosis Market Size by Cause
6.2.1 North America Pneumoconiosis Market Size by Cause (2016-2021)
6.2.2 North America Pneumoconiosis Market Size by Cause (2022-2027)
6.2.3 North America Pneumoconiosis Market Size by Cause (2016-2027)
6.3 North America Pneumoconiosis Market Size by Application
6.3.1 North America Pneumoconiosis Market Size by Application (2016-2021)
6.3.2 North America Pneumoconiosis Market Size by Application (2022-2027)
6.3.3 North America Pneumoconiosis Market Size by Application (2016-2027)
6.4 North America Pneumoconiosis Market Size by Country
6.4.1 North America Pneumoconiosis Market Size by Country (2016-2021)
6.4.2 North America Pneumoconiosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pneumoconiosis Market Size (2016-2027)
7.2 Europe Pneumoconiosis Market Size by Cause
7.2.1 Europe Pneumoconiosis Market Size by Cause (2016-2021)
7.2.2 Europe Pneumoconiosis Market Size by Cause (2022-2027)
7.2.3 Europe Pneumoconiosis Market Size by Cause (2016-2027)
7.3 Europe Pneumoconiosis Market Size by Application
7.3.1 Europe Pneumoconiosis Market Size by Application (2016-2021)
7.3.2 Europe Pneumoconiosis Market Size by Application (2022-2027)
7.3.3 Europe Pneumoconiosis Market Size by Application (2016-2027)
7.4 Europe Pneumoconiosis Market Size by Country
7.4.1 Europe Pneumoconiosis Market Size by Country (2016-2021)
7.4.2 Europe Pneumoconiosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pneumoconiosis Market Size (2016-2027)
8.2 Asia-Pacific Pneumoconiosis Market Size by Cause
8.2.1 Asia-Pacific Pneumoconiosis Market Size by Cause (2016-2021)
8.2.2 Asia-Pacific Pneumoconiosis Market Size by Cause (2022-2027)
8.2.3 Asia-Pacific Pneumoconiosis Market Size by Cause (2016-2027)
8.3 Asia-Pacific Pneumoconiosis Market Size by Application
8.3.1 Asia-Pacific Pneumoconiosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pneumoconiosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pneumoconiosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Pneumoconiosis Market Size by Region
8.4.1 Asia-Pacific Pneumoconiosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pneumoconiosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pneumoconiosis Market Size (2016-2027)
9.2 Latin America Pneumoconiosis Market Size by Cause
9.2.1 Latin America Pneumoconiosis Market Size by Cause (2016-2021)
9.2.2 Latin America Pneumoconiosis Market Size by Cause (2022-2027)
9.2.3 Latin America Pneumoconiosis Market Size by Cause (2016-2027)
9.3 Latin America Pneumoconiosis Market Size by Application
9.3.1 Latin America Pneumoconiosis Market Size by Application (2016-2021)
9.3.2 Latin America Pneumoconiosis Market Size by Application (2022-2027)
9.3.3 Latin America Pneumoconiosis Market Size by Application (2016-2027)
9.4 Latin America Pneumoconiosis Market Size by Country
9.4.1 Latin America Pneumoconiosis Market Size by Country (2016-2021)
9.4.2 Latin America Pneumoconiosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumoconiosis Market Size (2016-2027)
10.2 Middle East & Africa Pneumoconiosis Market Size by Cause
10.2.1 Middle East & Africa Pneumoconiosis Market Size by Cause (2016-2021)
10.2.2 Middle East & Africa Pneumoconiosis Market Size by Cause (2022-2027)
10.2.3 Middle East & Africa Pneumoconiosis Market Size by Cause (2016-2027)
10.3 Middle East & Africa Pneumoconiosis Market Size by Application
10.3.1 Middle East & Africa Pneumoconiosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pneumoconiosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pneumoconiosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Pneumoconiosis Market Size by Country
10.4.1 Middle East & Africa Pneumoconiosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pneumoconiosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Pneumoconiosis Introduction
11.1.4 Novartis Revenue in Pneumoconiosis Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Pneumoconiosis Introduction
11.2.4 Abbott Revenue in Pneumoconiosis Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Pneumoconiosis Introduction
11.3.4 Eli Lilly Revenue in Pneumoconiosis Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Sunpharma
11.4.1 Sunpharma Company Details
11.4.2 Sunpharma Business Overview
11.4.3 Sunpharma Pneumoconiosis Introduction
11.4.4 Sunpharma Revenue in Pneumoconiosis Business (2016-2021)
11.4.5 Sunpharma Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pneumoconiosis Introduction
11.5.4 Sanofi Revenue in Pneumoconiosis Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Pneumoconiosis Introduction
11.6.4 Novo Nordisk Revenue in Pneumoconiosis Business (2016-2021)
11.6.5 Novo Nordisk Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pneumoconiosis Introduction
11.7.4 AstraZeneca Revenue in Pneumoconiosis Business (2016-2021)
11.7.5 AstraZeneca Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pneumoconiosis Market Size Growth Rate by Cause (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Organic Dusts
Table 3. Key Players of Non-Organic Substances
Table 4. Global Pneumoconiosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pneumoconiosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pneumoconiosis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pneumoconiosis Market Share by Regions (2016-2021)
Table 8. Global Pneumoconiosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pneumoconiosis Market Share by Regions (2022-2027)
Table 10. Pneumoconiosis Market Trends
Table 11. Pneumoconiosis Market Drivers
Table 12. Pneumoconiosis Market Challenges
Table 13. Pneumoconiosis Market Restraints
Table 14. Global Pneumoconiosis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pneumoconiosis Market Share by Players (2016-2021)
Table 16. Global Top Pneumoconiosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumoconiosis as of 2020)
Table 17. Ranking of Global Top Pneumoconiosis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pneumoconiosis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pneumoconiosis Product Solution and Service
Table 21. Date of Enter into Pneumoconiosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pneumoconiosis Market Size by Cause (2016-2021) (US$ Million)
Table 24. Global Pneumoconiosis Revenue Market Share by Cause (2016-2021)
Table 25. Global Pneumoconiosis Forecasted Market Size by Cause (2022-2027) (US$ Million)
Table 26. Global Pneumoconiosis Revenue Market Share by Cause (2022-2027) & (US$ Million)
Table 27. Global Pneumoconiosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pneumoconiosis Revenue Market Share by Application (2016-2021)
Table 29. Global Pneumoconiosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pneumoconiosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pneumoconiosis Market Size by Cause (2016-2021) (US$ Million)
Table 32. North America Pneumoconiosis Market Size by Cause (2022-2027) & (US$ Million)
Table 33. North America Pneumoconiosis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pneumoconiosis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pneumoconiosis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pneumoconiosis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pneumoconiosis Market Size by Cause (2016-2021) (US$ Million)
Table 38. Europe Pneumoconiosis Market Size by Cause (2022-2027) & (US$ Million)
Table 39. Europe Pneumoconiosis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pneumoconiosis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pneumoconiosis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pneumoconiosis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pneumoconiosis Market Size by Cause (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pneumoconiosis Market Size by Cause (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pneumoconiosis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pneumoconiosis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pneumoconiosis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pneumoconiosis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pneumoconiosis Market Size by Cause (2016-2021) (US$ Million)
Table 50. Latin America Pneumoconiosis Market Size by Cause (2022-2027) & (US$ Million)
Table 51. Latin America Pneumoconiosis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pneumoconiosis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pneumoconiosis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pneumoconiosis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pneumoconiosis Market Size by Cause (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pneumoconiosis Market Size by Cause (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pneumoconiosis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pneumoconiosis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pneumoconiosis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pneumoconiosis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Pneumoconiosis Product
Table 64. Novartis Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Pneumoconiosis Product
Table 69. Abbott Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Pneumoconiosis Product
Table 74. Eli Lilly Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Sunpharma Company Details
Table 77. Sunpharma Business Overview
Table 78. Sunpharma Pneumoconiosis Product
Table 79. Sunpharma Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 80. Sunpharma Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Pneumoconiosis Product
Table 84. Sanofi Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Novo Nordisk Company Details
Table 87. Novo Nordisk Business Overview
Table 88. Novo Nordisk Pneumoconiosis Product
Table 89. Novo Nordisk Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 90. Novo Nordisk Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Pneumoconiosis Product
Table 94. AstraZeneca Revenue in Pneumoconiosis Business (2016-2021) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumoconiosis Market Share by Cause: 2020 VS 2027
Figure 2. Organic Dusts Features
Figure 3. Non-Organic Substances Features
Figure 4. Global Pneumoconiosis Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Pneumoconiosis Report Years Considered
Figure 9. Global Pneumoconiosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pneumoconiosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pneumoconiosis Market Share by Regions: 2020 VS 2027
Figure 12. Global Pneumoconiosis Market Share by Regions (2022-2027)
Figure 13. Global Pneumoconiosis Market Share by Players in 2020
Figure 14. Global Top Pneumoconiosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumoconiosis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pneumoconiosis Revenue in 2020
Figure 16. Global Pneumoconiosis Revenue Market Share by Cause (2016-2021)
Figure 17. Global Pneumoconiosis Revenue Market Share by Cause (2022-2027)
Figure 18. North America Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pneumoconiosis Market Share by Cause (2016-2027)
Figure 20. North America Pneumoconiosis Market Share by Application (2016-2027)
Figure 21. North America Pneumoconiosis Market Share by Country (2016-2027)
Figure 22. United States Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pneumoconiosis Market Share by Cause (2016-2027)
Figure 26. Europe Pneumoconiosis Market Share by Application (2016-2027)
Figure 27. Europe Pneumoconiosis Market Share by Country (2016-2027)
Figure 28. Germany Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pneumoconiosis Market Share by Cause (2016-2027)
Figure 36. Asia-Pacific Pneumoconiosis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pneumoconiosis Market Share by Region (2016-2027)
Figure 38. China Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pneumoconiosis Market Share by Cause (2016-2027)
Figure 46. Latin America Pneumoconiosis Market Share by Application (2016-2027)
Figure 47. Latin America Pneumoconiosis Market Share by Country (2016-2027)
Figure 48. Mexico Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pneumoconiosis Market Share by Cause (2016-2027)
Figure 52. Middle East & Africa Pneumoconiosis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pneumoconiosis Market Share by Country (2016-2027)
Figure 54. Turkey Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pneumoconiosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 58. Abbott Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 60. Sunpharma Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Pneumoconiosis Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の有機農業市場規模・現状・予測（2021年-2027年） Organic farming is a method that involves growing and nurturing crops with the use of biological materials preventing the use of synthetic based fertilizers and pesticides. Also, the use of genetically modified organisms is not permitted. Organic farming systems have a great potential to provide the…- 世界の有機正孔輸送層（HTL）市場規模・現状・予測（2021年-2027年） Organic Hole Transport material is a kind of semiconductor that can achieve charge transfer through the orderly migration of carriers when applied electric field. The main function of organic hole transport layers is to balance the injection and transportation of the hole, in order to improve the li…
- 世界の有機エレクトロニクス市場規模・現状・予測（2021年-2027年） Organic electronics is a field of materials science concerning the design, synthesis, characterization, and application of organic small molecules or polymers that show desirable electronic properties such as conductivity. In 2020, the global Organic Electronics market size will be US$ 44880 million…
- 世界の有機発光ダイオード（OLED）材料市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Organic Light-emitting Diode (OLED) Materials Market The global Organic Light-emitting Diode (OLED) Materials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy…
- 世界の有機家畜＆養鶏市場規模・現状・予測（2021年-2027年） Farms in the industry primarily produce certified organic livestock or poultry. Organic farming is free of synthetic chemicals, fertilisers or genetically modified organisms. The industry excludes farms that are primarily engaged in conventional livestock or poultry farming. The Organic Livestock an…